$5.28
-0.320 (-5.71%)
At Close: Jun 03, 2026
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
02:02pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin (NUS) Trims Q2 Revenue Guidance, Stock Declines
03:49pm, Friday, 08'th Jul 2022 Zacks Investment Research
Nu Skin (NUS) has been bearing the brunt of global uncertainties. Nonetheless, it believes that EmpowerMe strategy should support sequential improvements in the back half of the year.
Nu Skin stock declines following warning that revenue will be light
09:11pm, Thursday, 07'th Jul 2022 MarketWatchNu Skin stock declines following warning that revenue will be light
05:11pm, Thursday, 07'th Jul 2022
Nu Skin Enterprises Inc. shares dropped in the extended session Thursday after the skin-care and beauty products multi-level marketing company said second-quarter sales would be coming in light given
Helen of Troy (HELE) Surpasses Q1 Earnings and Revenue Estimates
12:05pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 24.23% and 8.27%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Down More Than 10% in 6 Months: Here's Why
11:53am, Wednesday, 29'th Jun 2022 Zacks Investment Research
Nu Skin (NUS) has been grappling with global uncertainties like rising pandemic-related factors, unfavorable currency rates and geopolitical conflicts.
Nu Skin (NUS) Down More Than 10% in 6 Months: Here's Why
09:20am, Wednesday, 29'th Jun 2022
Nu Skin (NUS) has been grappling with global uncertainties like rising pandemic-related factors, unfavorable currency rates and geopolitical conflicts.
Target And 2 Other Stocks Insiders Are Selling
11:59am, Thursday, 23'rd Jun 2022 Benzinga
US crude oil futures traded lower on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s prospects or that
Nu Skin (NUS) Up 8.8% Since Last Earnings Report: Can It Continue?
03:32pm, Friday, 03'rd Jun 2022 Zacks Investment Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nu Skin (NUS) Looks Troubled on Volatile Currency Movements
03:48pm, Wednesday, 01'st Jun 2022 Zacks Investment Research
Nu Skin Enterprises (NUS) has been encountering global uncertainties like rising pandemic-related factors, unfavorable currency rates and geopolitical conflicts.
Nu Skin (NUS) Looks Troubled on Volatile Currency Movements
01:33pm, Wednesday, 01'st Jun 2022
Nu Skin Enterprises (NUS) has been encountering global uncertainties like rising pandemic-related factors, unfavorable currency rates and geopolitical conflicts.
Dividend Champion, Contender, And Challenger Highlights: Week Of May 22
05:04am, Sunday, 22'nd May 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Nu Skin: Hoping Any Potential Downturn Will Be Swift In Nature
10:25am, Wednesday, 18'th May 2022
Nu Skin beat top and bottom line estimates in Q1. Growth though is on the wane.
Nu Skin Enterprises (NUS) Q1 Earnings and Revenues Top Estimates
11:05pm, Wednesday, 04'th May 2022 Zacks Investment Research
Nu Skin (NUS) delivered earnings and revenue surprises of 4.11% and 4.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin Enterprises' (NUS) CEO Ryan Napierski on Q1 2022 Results - Earnings Call Transcript
09:29pm, Wednesday, 04'th May 2022
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Scott Pond – Vice President-Investor Relations Ryan Napierski – President and Chi
Sign In
Buy NUS